Report: the global smart pills market will reach 9 billion US dollars in 2024

Source: Biovalley 2015-03-30 smart pills refer to the drugs containing micro sensors that can release drug ingredients in patients and feed back to patients through signals The attractive prospect of intelligent pill technology in complex endoscopic surgery, drug control and release, patient remote monitoring and other aspects is also promoting the application and development of this technology in these areas At present, intelligent pill technology has been more and more adopted by the global health care industry to improve efficiency and eliminate endoscopic detection surgery Recently, the latest research report released by the US Market Research Institute markets and markets pointed out that the market value of the global intelligent pill Market was US $1.56 billion in 2014 In the next 10 years (2014-2024), the market will develop rapidly, and it is expected to grow at a CAGR of 16.16% in 2014-2020, reaching US $3.83 billion by 2020; while in 2020-2024 In 2024, CAGR will reach 23.7% and 8.98 billion US dollars The favorable policies of government to adopt capsule endoscope, the preference of patients for mini invasive surgery, the technological progress of endoscopic surgery and the rising incidence rate of gastrointestinal cancer are favorable factors for the development of the global intelligent pill Market In addition, the benefits provided by intelligent pill technology, such as endoscopic surgery, targeted drug delivery, and technical progress in simplifying patient remote monitoring, also promote the adoption of this technology However, there are still some development obstacles in this field, such as immature capsule endoscopy technology, high cost, patients' fear of swallowing chips, which restrict the development of the global intelligent pill Market According to the application division, the intelligent pill market can be subdivided into capsule endoscopy, drug delivery and patient monitoring Among them, capsule endoscopy market occupies the largest market share According to the geographical division, the global intelligent pill market can be subdivided into North America, Europe, Asia and the rest of the world (row) Among them, North America occupies the largest market share Favorable reimbursement policies, FDA's approval of intelligent pills, and the growth of government and other institutions' investment in intelligent pills are favorable factors to promote the rapid growth of intelligent pill Market in the region Asia is a relatively new market However, favorable changes in reimbursement policies in some countries (such as Japan), investment of related enterprises and support of endoscopic research will promote the rapid development of the market in the region According to the report, the main players in the global smart pill Market include capsovision (US), given imaging (Israel), medimetrics SA de C.V (Mexico), Olympus (Japan) and bio images (UK)